Abstract
Tacrolimus, a potent immunosuppressant, is used for the prevention of allograft rejection in organ transplantation. Tacrolimus trough concentration (TTC) is still widely used as a guide to individualizing tacrolimus dose requirements in renal transplantation. The aim was to investigate the effect of patient’s gender on TTC in renal transplant recipients on quaternary immunosuppressive therapy (tacrolimus, mycophenolate mofetil, prednisone, and anti–T lymphocyte globulin).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.